Beijing Tongrentang (SHA:600085), through branch Tongrentang Pharmaceutical Factory, obtained a class III product license from Health Canada for the Shiyi Qingwen Pills, according to a Shanghai bourse filing on Thursday.
The traditional Chinese medicine is used to eliminate heat toxins and treat viral influenza, headache, body aches and chills.
The drugmaker's shares fell 2% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments